Steve E. Krognes's Net Worth
$4.77 Million
Who is Steve E. Krognes?
Steve E. Krognes has an estimated net worth of $4.77 Million. This is based on reported shares across multiple companies, which include Guardant Health, Inc., Gritstone Oncology, Inc., Denali Therapeutics Inc., Corvus Pharmaceuticals, Inc., and PLIANT THERAPEUTICS, INC..
SEC CIK
Steve E. Krognes's CIK is 0001666236
Past Insider Trading and Trends
2024 was Steve E. Krognes's most active year for acquiring shares with 14 total transactions. Steve E. Krognes's most active month to acquire stocks was the month of May. 2024 was Steve E. Krognes's most active year for disposing of shares, totalling 16 transactions. Steve E. Krognes's most active month to dispose stocks was the month of January. 2022 saw Steve E. Krognes paying a total of $42,500.00 for 224,784 shares, this is the most they've acquired in one year. In 2024 Steve E. Krognes cashed out on 137,700 shares for a total of $2,725,873.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Guardant Health, Inc. (GH) Snapshot price: $24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.58% | 154 |
—
|
—
| 9.91K |
Oct 31
| |||
Form 4
| +1.64% | 155 |
—
|
—
| 9.6K |
Aug 31
| |||
Form 4
| +1.66% | 154 |
—
|
—
| 9.45K |
Jul 31
| |||
Form 4
| +1.68% | 154 |
—
|
—
| 9.29K |
Jun 30
| |||
Form 4
| +157.61% | 5.59K |
—
|
—
| 9.14K |
Jun 12
| |||
Form 4
| +4.57% | 155 |
—
|
—
| 3.55K |
May 31
| |||
Form 4
| +4.75% | 154 |
—
|
—
| 3.39K |
Apr 30
| |||
Form 4
| +4.99% | 154 |
—
|
—
| 3.24K |
Mar 31
| |||
Form 4
| +5.25% | 154 |
—
|
—
| 3.08K |
Feb 29
| |||
Form 4
| +5.58% | 155 |
—
|
—
| 2.93K |
Jan 31
| |||
Form 4
| +5.87% | 154 |
—
|
—
| 2.78K |
Dec 31
| |||
Form 4
| +6.24% | 154 |
—
|
—
| 2.62K |
Nov 30
| |||
Form 4
| +6.66% | 154 |
—
|
—
| 2.47K |
Oct 31
| |||
Form 4
| +7.18% | 155 |
—
|
—
| 2.31K |
Sep 30
| |||
Form 4
| +7.68% | 154 |
—
|
—
| 2.16K |
Aug 31
| |||
Form 4
| +8.32% | 154 |
—
|
—
| 2K |
Jul 31
| |||
Form 4
|
∞
| 1.85K |
—
|
—
| 1.85K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gritstone Oncology, Inc. (GRTS) Snapshot price: $0.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Denali Therapeutics Inc. (DNLI) Snapshot price: $25.25
CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.76% | -30.00K |
$29.03 | -$870,900.00 | 29.1K |
Scheduled
|
Sep 30
| ||
Form 4
| -5.02% | -1.73K |
$23.79 | -$41,085.33 | 32.68K |
Aug 20
| |||
Form 4
| -26.07% | -30.69K |
$21.96 | -$678,659.52 | 87.02K |
Scheduled
|
Jun 13 - Jul 1
| ||
Form 4
| +12.60% | 5.97K |
—
|
—
| 53.31K |
May 31
| |||
Form 4
| -66.15% | -92.50K |
$20.50 | -$1,896,250.00 | 47.34K |
Scheduled
|
Apr 1
| ||
Form 4
| -1.93% | -2.75K |
$17.29 | -$47,547.50 | 139.84K |
Feb 13
| |||
Form 4
| -2.20% | -3.21K |
$19.43 | -$62,331.44 | 142.59K |
Jan 5
| |||
Form 4
| -0.96% | -1.42K |
$22.60 | -$32,069.40 | 145.8K |
Aug 21
| |||
Form 4
| +2.95% | 4.22K |
—
|
—
| 147.22K |
Jun 1
| |||
Form 4
| -1.46% | -2.12K |
$30.10 | -$63,781.90 | 143K |
Feb 13
| |||
Form 4
| -0.94% | -1.38K |
$30.88 | -$42,521.76 | 145.12K |
Feb 8
| |||
Form 4
| -1.99% | -2.97K |
$28.44 | -$84,466.80 | 146.5K |
Jan 5
| |||
Form 4
| -1.48% | -2.25K |
$33.22 | -$74,844.66 | 149.47K |
Aug 19
| |||
Form 4
| +70.05% | 62.5K |
$0.68 | $42,500.00 | 151.72K |
Jul 19
| |||
Form 4
| -2.09% | -2.56K |
$34.69 | -$88,806.40 | 120.22K |
Feb 11
| |||
Form 4
| -1.04% | -1.30K |
$37.09 | -$48,072.66 | 122.78K |
Feb 9
| |||
Form 4
| -1.76% | -2.23K |
$44.75 | -$99,568.75 | 124.08K |
Jan 5
| |||
Form 4
| +32.53% | 31K |
—
|
—
| 126.3K |
Jan 3
| |||
Form 4
| -2.34% | -2.29K |
$49.57 | -$113,263.20 | 95.3K |
Aug 19
| |||
Form 4
| -5.56% | -50.00K |
$61.89 | -$3,094,563.14 | 850K |
Scheduled
|
Mar 15
| ||
Form 4
| -5.26% | -50.00K |
$65.09 | -$3,254,710.04 | 900K |
Scheduled
|
Feb 16
| ||
Form 4
| -3.02% | -3.04K |
$70.34 | -$213,479.69 | 97.59K |
Feb 11
| |||
Form 4
| +27.53% | 2.8K |
$74.68 | -$108,134.54 | 12.98K |
Feb 7 - Feb 9
| |||
Form 4
| -5.00% | -50.00K |
$71.45 | -$3,572,556.33 | 950K |
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +0.37% | 3.69K |
$32.87 | -$64,227.98 | 1.01M |
Aug 20 - Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
| -0.14% | -1.43K |
$19.48 | -$27,817.44 | 1.01M |
Mar 30
| |||
Form 4/A
| +0.42% | 4.25K |
—
|
—
| 1.01M |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +0.37% | 3.67K |
$18.59 | -$36,745.31 | 1M |
Aug 20 - Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +100.00% | 500K |
—
|
—
| 1M |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corvus Pharmaceuticals, Inc. (CRVS) Snapshot price: $3.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $12.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||